Data on Sepsis Detailed by Researchers at Affiliated Suzhou Hospital of Nanjing Medical University (A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China).

Keywords: Antibiotics; Antiinfectives; Asia; Beta-Lactam Resistance; Blood Diseases and Conditions; Bloodstream Infection; China; Drug Resistance; Drugs and Therapies; Glycopeptide Antibiotics; Glycopeptides Therapy; Health and Medicine; Hospitals; Linezolid Therapy; Methicillin Resistance; Penicillin Resistance; Peptides; Pharmaceuticals; Sepsis; Septicemia; Vancomycin Therapy EN Antibiotics Antiinfectives Asia Beta-Lactam Resistance Blood Diseases and Conditions Bloodstream Infection China Drug Resistance Drugs and Therapies Glycopeptide Antibiotics Glycopeptides Therapy Health and Medicine Hospitals Linezolid Therapy Methicillin Resistance Penicillin Resistance Peptides Pharmaceuticals Sepsis Septicemia Vancomycin Therapy 84 84 1 08/07/23 20230810 NES 230810 2023 AUG 10 (NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- A new study on sepsis is now available. For more information on this research see: A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China. [Extracted from the article]